Market Research Report
Syndromic Multiplex Diagnostic Markets with Covid-19 Impact. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Country. with Market Analysis, Executive Guides and Customization. 2020 to 2024
|Published by||Howe Sound Research||Product code||939942|
|Published||Content info||399 Pages
Delivery time: 1-2 business days
|Syndromic Multiplex Diagnostic Markets with Covid-19 Impact. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Country. with Market Analysis, Executive Guides and Customization. 2020 to 2024|
|Published: June 2, 2020||Content info: 399 Pages||
How will COVID-19 affect Syndromic and Infectious Disease Diagnostics? The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?
Syndromic testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size out to 2024. In a special section the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel based ordering of infectious disease tests.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes: